fda changes semaglutide How Long Has Been Studied? Research Timeline The Wild East of semaglutide

A strong signal that medication is one part of good obesity care, not the whole of it

Given that obesity in adolescence is already associated with an increased risk of depression and suicidal ideation, and considering the rise in GLP-1 receptor agonist prescriptions since FDA approval in 2020, it was crucial to investigate whether this treatment impacts psychiatric outcomes

The longer that food in your stomach, the greater the chance it will create gas that needs to go out

Heart rate: GLP-1 RAs tend to raise resting heart rate by 24 beats per minute

Consistently, DM significantly increased the cardiovascular mortality, all-cause mortality, hospitalization rate and prognosis of patients with HFpEF [30, 36, 37]

They were designed and tested to be used continuously, experts said